Boellaard R - Search Results

1

Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.

Kobe C, Scheffler M, Holstein A, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Dietlein M, Wolf J, Kahraman D. Kobe C, et al. Among authors: boellaard r. Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1117-27. doi: 10.1007/s00259-012-2118-8. Epub 2012 Apr 14. Eur J Nucl Med Mol Imaging. 2012. PMID: 22526960

2

Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET.

Boellaard R, van Lingen A, van Balen SC, Hoving BG, Lammertsma AA. Boellaard R, et al. Eur J Nucl Med. 2001 Jan;28(1):81-9. doi: 10.1007/s002590000405. Eur J Nucl Med. 2001. PMID: 11202456 Clinical Trial.

3

Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling.

Boellaard R, van Lingen A, Lammertsma AA. Boellaard R, et al. J Nucl Med. 2001 May;42(5):808-17. J Nucl Med. 2001. PMID: 11337581 Free article.

4

Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans.

van der Weerdt AP, Klein LJ, Boellaard R, Visser CA, Visser FC, Lammertsma AA. van der Weerdt AP, et al. Among authors: boellaard r. J Nucl Med. 2001 Nov;42(11):1622-9. J Nucl Med. 2001. PMID: 11696630 Free article. Clinical Trial.

5

Attenuation correction of PET activation studies in the presence of task-related motion.

van den Heuvel OA, Boellaard R, Veltman DJ, Mesina C, Lammertsma AA. van den Heuvel OA, et al. Among authors: boellaard r. Neuroimage. 2003 Aug;19(4):1501-9. doi: 10.1016/s1053-8119(03)00216-7. Neuroimage. 2003. PMID: 12948706

6

(R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation.

Luurtsema G, Molthoff CF, Windhorst AD, Smit JW, Keizer H, Boellaard R, Lammertsma AA, Franssen EJ. Luurtsema G, et al. Among authors: boellaard r. Nucl Med Biol. 2003 Oct;30(7):747-51. doi: 10.1016/s0969-8051(03)00078-7. Nucl Med Biol. 2003. PMID: 14499333

7

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. Verel I, et al. Among authors: boellaard r. J Nucl Med. 2003 Oct;44(10):1663-70. J Nucl Med. 2003. PMID: 14530484 Free article.

8

Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods.

Greuter HN, Boellaard R, van Lingen A, Franssen EJ, Lammertsma AA. Greuter HN, et al. Among authors: boellaard r. J Nucl Med Technol. 2003 Dec;31(4):206-9. J Nucl Med Technol. 2003. PMID: 14657286 Free article.

9

The perfusable tissue index: a marker of myocardial viability.

Knaapen P, Boellaard R, Götte MJ, van der Weerdt AP, Visser CA, Lammertsma AA, Visser FC. Knaapen P, et al. Among authors: boellaard r. J Nucl Cardiol. 2003 Nov-Dec;10(6):684-91. doi: 10.1016/s1071-3581(03)00656-1. J Nucl Cardiol. 2003. PMID: 14668782 Review. No abstract available.

10

Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology.

Joshi U, Hoekstra OS, Boellaard R, Comans EF, Raijmakers PG, Pijpers RJ, Miller SD, Teule GJ, van Lingen A. Joshi U, et al. Among authors: boellaard r. Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):596-8. doi: 10.1007/s00259-003-1440-6. Epub 2004 Jan 14. Eur J Nucl Med Mol Imaging. 2004. PMID: 14722683 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters